NCT03526081 is a NA clinical trial of Chamomile Tea in Healthy, sponsored by University of California, Davis.

Who is sponsoring NCT03526081?

NCT03526081 is sponsored by University of California, Davis.

What drugs are being tested in NCT03526081?

Interventions in NCT03526081: Chamomile Tea, Parsley based drink, Parsley Yogurt, Apigenin, Parsley-based drink (II).

Is NCT03526081 still recruiting?

NCT03526081 is currently completed. Last updated 23 May 2019.

Last reviewed 2019-05-23 · How we verify

NCT03526081

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides

Completed NA Last updated 23 May 2019

What this trial tests

NA trial testing Chamomile Tea in Healthy in 17 participants. Completed in 30 July 2016.

Timeline

20 January 2015

Primary endpoint
30 July 2016

30 July 2016

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	17
Start date	20 January 2015
Primary completion	30 July 2016
Estimated completion	30 July 2016
Sites	2 locations across United States

Drugs / interventions tested

Chamomile Tea — full drug profile →
Parsley based drink
Parsley Yogurt
Apigenin
Parsley-based drink (II)

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of California, Davis

Who can join

Adults 25 to 60, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Probe dietary intervention study in healthy young adult males to evaluate the concentration of apigenin derived metabolites in plasma and urine after single acute intakes of different apigenin-containing test materials.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

TGF-β signaling in the tumor metabolic microenvironment and targeted therapies.
Shi X, Yang J, Deng S, Xu H, et al · · 2022 · cited 188× · PMID 36115986 · DOI 10.1186/s13045-022-01349-6
Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment.
Zhang J, Xu HX, Zhu JQ, Dou YX, et al · · 2023 · cited 49× · PMID 37416770 · DOI 10.7150/ijbs.82401
Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults.
Borges G, Fong RY, Ensunsa JL, Kimball J, et al · · 2022 · cited 24× · PMID 35452808 · DOI 10.1016/j.freeradbiomed.2022.04.007
Fibroblast PI3K/AKT signaling and extracellular matrix homeostasis: mechanisms, targets, and delivery challenges.
Fang C, Zeng Z, Ni B, Wen X, et al · · 2025 · PMID 41509070 · DOI 10.3389/fcell.2025.1681875

Verify or expand the search:

Other trials of Chamomile Tea

Trials testing the same drug.

NCT05272475 — The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers · NA · completed
NCT05006378 — Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers · NA · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03526081 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 23 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing